tiprankstipranks
Trending News
More News >
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market
Advertisement

Sonoma Pharmaceuticals (SNOA) Financial Statements

Compare
320 Followers

Sonoma Pharmaceuticals Financial Overview

Sonoma Pharmaceuticals's market cap is currently $5.90M. The company's EPS TTM is $-0.152; its P/E ratio is ―; Sonoma Pharmaceuticals is scheduled to report earnings on June 17, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue$ 14.29M$ 12.73M$ 13.27M$ 12.63M$ 18.63M
Gross Profit$ 5.46M$ 4.75M$ 4.48M$ 3.99M$ 6.56M
Operating Income$ -3.71M$ -4.70M$ -4.57M$ -5.89M$ -3.45M
EBITDA$ -3.57M$ -4.53M$ -4.45M$ -5.70M$ -3.22M
Net Income$ -3.46M$ -4.83M$ -5.15M$ -5.09M$ -4.62M
Balance Sheet
Cash & Short-Term Investments$ 5.37M$ 3.13M$ 3.82M$ 7.40M$ 4.22M
Total Assets$ 13.69M$ 14.74M$ 16.23M$ 18.84M$ 14.99M
Total Debt$ 305.00K$ 608.00K$ 849.00K$ 1.37M$ 2.67M
Net Debt$ -5.07M$ -2.52M$ -2.97M$ -6.03M$ -1.54M
Total Liabilities$ 9.28M$ 8.60M$ 8.25M$ 10.15M$ 9.62M
Stockholders' Equity$ 4.41M$ 6.14M$ 7.98M$ 8.70M$ 5.36M
Cash Flow
Free Cash Flow$ -168.00K$ -2.42M$ -6.42M$ -4.38M$ -3.56M
Operating Cash Flow$ -88.00K$ -2.40M$ -6.15M$ -4.25M$ -3.38M
Investing Cash Flow$ -80.00K$ -2.00K$ -258.00K$ -99.00K$ 388.00K
Financing Cash Flow$ 3.03M$ 1.68M$ 2.49M$ 7.40M$ 3.31M
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Sonoma Pharmaceuticals Debt to Assets

Sonoma Pharmaceuticals Cash Flow

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis